Viewing nowTelmisartan 80 mg Tablet
Telmisartan 80mg
Tablet · Prescription medication
NBK Pharmaceutical Co., Ltd.

MFDS item code 201903461 · Approved 2019.05.28 · Insurance code 054800290
Treatment of essential hypertension and prevention of cardiovascular disease (myocardial infarction, stroke, etc.)
This medication is used to treat essential hypertension. Additionally, it helps reduce the risk of death from myocardial infarction, stroke, and cardiovascular disease in high-risk diabetic patients with a history of coronary artery disease, peripheral artery disease, stroke, or transient ischemic attacks, or evidence of end-organ damage. It is effective as alternative therapy when ACE inhibitors cannot be used in these patients. Therefore, this medication is used to control blood pressure and reduce the risk of cardiovascular complications.
1. Essential hypertension Adults: Telmisartan should be administered orally at a dose of 40 mg once daily with water, and may be taken regardless of meals. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after initiation of treatment. This drug produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of the risk of cardiovascular disease Adults: It is recommended that this drug be administered orally at a dose of 80 mg once daily with water, and it may be taken regardless of meals. The risk-reduction effect on cardiovascular disease morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this drug to reduce the risk of cardiovascular disease, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This drug can cause serious harm, especially to the fetus and newborn, during pregnancy; it should be discontinued immediately if pregnancy is confirmed. It should not be used in individuals allergic to this drug or its components, pregnant or potentially pregnant women, breastfeeding women, patients with severe liver disease or cholestasis, patients with hereditary angioedema, and patients with diabetes or severe kidney disease. Elderly patients, those with hyperkalemia, mild to moderate liver impairment, specific heart diseases, gastrointestinal disorders, renal artery hypertension, and severe kidney impairment should use this medication cautiously. During medication, various adverse reactions such as infections, blood abnormalities, allergic reactions, hyperkalemia, hypoglycemia, neurological symptoms, cardiovascular abnormalities, respiratory distress, gastrointestinal disorders, liver function abnormalities, skin reactions, muscle pain, kidney impairment, etc., may occur; immediate consultation with healthcare professionals is advised if any unusual symptoms appear. Particularly, serious side effects such as angioedema, hyperkalemia, renal dysfunction, shock, or syncope, liver dysfunction, interstitial pneumonia, and rhabdomyolysis may occur, necessitating careful observation. Patients with renal impairment or decreased blood volume should thoroughly check their condition before taking this medication, and appropriate actions should be taken immediately if symptoms of hypotension arise. This drug may interact with other antihypertensive medications, certain diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., so it is essential to inform healthcare providers of any medications being taken. Women who are pregnant or breastfeeding are advised not to take this medication, and if it is necessary, it should be carefully decided after consulting a specialist. Safety and efficacy have not been established for children under 18 years; therefore, it is not recommended. Elderly patients should be carefully monitored for the risk of stroke and other complications due to excessive blood pressure lowering when taking this medication. In case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, so immediate medical attention and appropriate treatment should be sought. This medication should be kept out of reach of children and not transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature.
White round tablet
Bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 80mg
Tablet · Prescription medication
NBK Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.